Endoglycosidase-assisted peptide mapping
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsHaibo Qiu, Jieqiang Zhong, Ming Huang, Ning Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsHaibo Qiu, Jieqiang Zhong, Ming Huang, Ning Li
Estimating the term…
Endoglycosidase-assisted peptide mapping workflow systems for mass spectrometry (MS) characterization of non-consensus N-glycosylation in monoclonal antibodies (mAbs) are disclosed. The feasibility of the workflow was demonstrated by an atypical glycosite located within an NPNNXN (SEQ ID NO: 1) sequence in a 25-residue tryptic peptide. With the aids of endoglycosidase treatment, the resulting truncated glycan structures improved peptide ionization efficiency in MS and hence facilitated reliable quantitation of glycosite occupancy. The remaining mono-/di-saccharides served as a large mass tag allowing differentiation between the glycopeptide and deamidated peptide, thus allowing for database searching for glycosite localization and automation of the data processing workflow. This workflow offers an efficient solution for characterizing non-consensus N-glycosylation for the development of therapeutic mAbs.
A system for endoglycosidase-assisted peptide mapping workflow for a protein comprising non-consensus N-glycosylation, wherein the system comprises the steps of:
A method of identifying non-consensus N-glycosylation and quantifying glycosylation occupancy in a protein, wherein the methods comprise the steps of
A method of identifying non-consensus N-glycosylation and quantifying glycosylation occupancy in a protein, wherein the methods comprise the steps of
Dependencies are inferred from the claim text.